乳腺癌和化疗影响中的增殖标志物:综合性审查
Aryan Salahi-Niri1, Paniz Zarand1, Fatemeh Shojaeian2
1Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research, Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran.
Health science reports
|April 9, 2025
概括
像Ki-67,MCM和PCNA这样的增殖标志物对于预测乳腺癌化疗反应至关重要. 数字病理学整合有望改善个性化治疗策略,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 生物标志物 生物标志物
背景情况:
- 乳腺癌是全球女性癌症死亡的主要原因之一.
- 预测化疗的益处仍然是一个临床挑战.
- 增殖标记提供了关于瘤生长和治疗反应的见解.
研究的目的:
- 审查Ki-67,迷你染色体维护 (MCM) 蛋白质和增殖细胞核抗原 (PCNA) 在乳腺癌中的临床作用.
- 评估它们对化疗反应的影响.
- 探索新兴的数字病理学技术用于标记物量化.
主要方法:
- 对Ki-67,MCM,PCNA,乳腺癌和化疗的研究进行了叙述性审查.
- 在PubMed,Scopus和谷歌学者中进行了搜索.
- 对2000-2023年出版物的图书统计分析使用R和VOSviewer进行.
主要成果:
- 基-67是新辅助化疗反应的关键预测因子.
- 在瘤等级中,MCM蛋白显示出有前途;PCNA与侵略性特征相关.
- 化疗后的Ki-67改变影响生存率;研究正在转向临床应用和数字定量.
结论:
- 在乳腺癌管理中,增殖标记是必不可少的.
- 基-67,MCM和PCNA提供预后和预测信息.
- 将标记物与数字病理学和人工智能的整合可以增强个性化治疗.
更多相关视频
08:26Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
24.8K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
